A real-world feasibility study: at home longitudinal use of the Cumulus NeuLogiq® platform for electrophysiological and neurocognitive measures in patients with mild Alzheimer's Disease dementia - Quiz - MDSpire

A real-world feasibility study: at home longitudinal use of the Cumulus NeuLogiq® platform for electrophysiological and neurocognitive measures in patients with mild Alzheimer's Disease dementia

  • By

  • Shannon Diggin

  • Laura Rueda-Delgado

  • Alison Buick

  • John F. Dyer

  • Azar Alexander-Sefre

  • Florentine Barbey

  • James B. Rowe

  • Kinan Muhammed

  • Brian T. Harel

  • Bryan J. Hansen

  • Elizabeth Tunbridge

  • Robert Lai

  • David J. Hawellek

  • Ann Marie Hake

  • Hugh Marston

  • Ashwini Oswal

  • Elizabeth Coulthard

  • Vivek Pattan

  • Victoria Evans

  • Stuart Gibson

  • Christopher Kipps

  • Rouba Kozak

  • Nick Mannering

  • Mark Moss

  • Viet Nguyen

  • Kenneth Ruddock

  • Leslie A. Shinobu

  • Sofia Toniolo

  • Brian Murphy

  • June 26, 2026

  • 0 min

Share

Original Source(s)

A real-world feasibility study: at home longitudinal use of the Cumulus NeuLogiq® platform for electrophysiological and neurocognitive measures in patients with mild Alzheimer's Disease dementia

  • by Shannon Diggin, Laura Rueda-Delgado, Alison Buick, John F. Dyer, Azar Alexander-Sefre, Florentine Barbey, James B. Rowe, Kinan Muhammed, Brian T. Harel, Bryan J. Hansen, Elizabeth Tunbridge, Robert Lai, David J. Hawellek, Ann Marie Hake, Hugh Marston, Ashwini Oswal, Elizabeth Coulthard, Vivek Pattan, Victoria Evans, Stuart Gibson, Christopher Kipps, Rouba Kozak, Nick Mannering, Mark Moss, Viet Nguyen, Kenneth Ruddock, Leslie A. Shinobu, Sofia Toniolo, Brian Murphy

  • June 26, 2026

Related Content

Oxidative stress markers in bipolar disorder and first-degree relatives: differential associations of ischemia-modified albumin and superoxide dismutase

Correction to: cGAS-STING agonists in preclinical glioblastoma animal models: a systematic review of tumor microenvironment modulation and survival outcomes

Serum uric acid-to-HDL cholesterol ratio and stroke prevalence: NHANES 1999–2018 with external support from an imaging-confirmed hemorrhagic stroke dataset